Theravance Bio: Q3 Earnings Snapshot
GEORGE TOWN, Cayman Islands (AP) — GEORGE TOWN, Cayman Islands (AP) — Theravance Biopharma Inc. (TBPH) on Tuesday reported a loss of $9 million in its third quarter.
The George Town, Cayman Islands-based company said it had a loss of 17 cents per share. Losses, adjusted for stock option expense and non-recurring costs, were 1 cent per share.
The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 10 cents per share.
The biopharmaceutical company posted revenue of $15.7 million in the period, which also topped Street forecasts. Three analysts surveyed by Zacks expected $15.6 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TBPH at https://www.zacks.com/ap/TBPH
